Correlation Between Bruker and MaxCyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bruker and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bruker and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bruker and MaxCyte, you can compare the effects of market volatilities on Bruker and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bruker with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bruker and MaxCyte.

Diversification Opportunities for Bruker and MaxCyte

BrukerMaxCyteDiversified AwayBrukerMaxCyteDiversified Away100%
0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bruker and MaxCyte is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Bruker and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and Bruker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bruker are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of Bruker i.e., Bruker and MaxCyte go up and down completely randomly.

Pair Corralation between Bruker and MaxCyte

Given the investment horizon of 90 days Bruker is expected to generate 1.19 times more return on investment than MaxCyte. However, Bruker is 1.19 times more volatile than MaxCyte. It trades about -0.23 of its potential returns per unit of risk. MaxCyte is currently generating about -0.46 per unit of risk. If you would invest  5,559  in Bruker on December 9, 2024 and sell it today you would lose (718.00) from holding Bruker or give up 12.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bruker  vs.  MaxCyte

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -10010203040
JavaScript chart by amCharts 3.21.15BRKR MXCT
       Timeline  
Bruker 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bruker has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's forward-looking signals remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar4550556065
MaxCyte 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar3.544.55

Bruker and MaxCyte Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-4.24-3.17-2.11-1.050.00.941.92.873.844.81 0.0300.0350.0400.0450.0500.0550.060
JavaScript chart by amCharts 3.21.15BRKR MXCT
       Returns  

Pair Trading with Bruker and MaxCyte

The main advantage of trading using opposite Bruker and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bruker position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.
The idea behind Bruker and MaxCyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences